Patents by Inventor James Joseph Gibbons

James Joseph Gibbons has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Anti-tumor activity of CCI-779 in papillary renal cell cancer
    Patent number: 8791097
    Abstract: This invention provides the method or use of CCI-779 in the treatment of papillary renal cell carcinoma.
    Type: Grant
    Filed: April 8, 2008
    Date of Patent: July 29, 2014
    Assignee: Wyeth LLC
    Inventors: Gary Dukart, James Joseph Gibbons, Jr., Anna Berkenblit, Jay Marshall Feingold
  • ANTI-TUMOR ACTIVITY OF CCI-779 IN PAPILLARY RENAL CELL CANCER
    Publication number: 20080255177
    Abstract: This invention provides the method or use of CCI-779 in the treatment of papillary renal cell carcinoma.
    Type: Application
    Filed: April 8, 2008
    Publication date: October 16, 2008
    Applicant: Wyeth
    Inventors: GARY DUKART, James Joseph Gibbons, Anna Berkenblit, Jay Marshall Feingold
  • Antineoplastic combinations
    Publication number: 20030008923
    Abstract: This invention provides the use of a combination of an mTOR inhibitor and an antineoplastic alkylating agent in the treatment of neoplasms.
    Type: Application
    Filed: May 29, 2002
    Publication date: January 9, 2003
    Applicant: Wyeth
    Inventors: Gary Dukart, James Joseph Gibbons
  • Antineoplastic combinations
    Publication number: 20020198137
    Abstract: This invention provides the use of a combination of CCI-779 and an antineoplastic alkylating agent in the treatment of neoplasms.
    Type: Application
    Filed: May 29, 2002
    Publication date: December 26, 2002
    Applicant: Wyeth
    Inventors: Gary Dukart, James Joseph Gibbons